Intuitive Surgical ISRG financials

Healthcare & Pharma ยท Statements and segments from its SEC filings, 2007 to 2025.

Intuitive Surgical revenue, gross and operating margin, net income, free cash flow, cash and debt by quarter and by fiscal year, and revenue by segment, read from the company's own filings with the US Securities and Exchange Commission. Free to everyone; the Risk & Quality report that scores the company is the paid step.

  • revenue by product: Instruments and accessories, Systems, Service

The numbers

Annual figures

LineFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$2.7B$3.1B$3.7B$4.5B$4.4B$5.7B$6.2B$7.1B$8.4B$10.1B
Gross profit$1.9B$2.2B$2.6B$3.1B$2.9B$4B$4.2B$4.7B$5.6B$6.6B
Operating income$949.7M$1.1B$1.2B$1.4B$1B$1.8B$1.6B$1.8B$2.3B$2.9B
Net income$738.3M$670.9M$1.1B$1.4B$1.1B$1.7B$1.3B$1.8B$2.3B$2.9B
EPS (diluted)$6.26$5.77$9.49$3.85$2.94$4.66$3.65$5.03$6.42$7.87
Operating cash flow$1.1B$1.1B$1.2B$1.6B$1.5B$2.1B$1.5B$1.8B$2.4B$3B
Free cash flow$1B*$953.2M*$982.2M*$1.2B*$1.1B*$1.7B*$958.4M*$749.6M*$1.3B*$2.5B*
Cash & equivalents$1B$648.2M$857.9M$1.2B$1.6B$1.3B$1.6B$2.8B$2B$3.4B
Gross margin69.9%70.2%69.9%69.4%65.6%69.3%67.4%66.4%67.5%66.0%
Operating margin35.1%33.9%32.2%30.7%24.1%31.9%25.3%24.8%28.1%29.3%
Net margin27.3%21.4%30.3%30.8%24.3%29.9%21.3%25.2%27.8%28.4%

Latest quarters

LineQ3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Revenue$2B$2.4B*$2.3B$2.4B$2.5B$2.9B*$2.8B$2.9B
Gross profit$1.4B$1.6B*$1.5B$1.6B$1.7B$1.9B*$1.8B$2B
Operating income$577.3M$734.9M*$578.1M$743.4M$759.7M$864.3M*$855.3M$971.9M
Net income$565.1M$685.7M*$698.4M$658.4M$704.4M$794.8M*$821.5M$818.1M
EPS (diluted)$1.56$1.89*$1.92$1.81$1.95$2.20*$2.28$2.29
Operating cash flow$706.5M*$822.6M*$581.6M$715.4M*$841M*$892.5M*$911.9M$1.1B*
Free cash flow$458.6M*$510.6M*$465M*$560.1M*$735.6M*$730M*$808.6M*$948.4M*
Cash & equivalents$2.4B$2B$2.6B$3.4B$2.8B$3.4B$2B$2.8B
Gross margin67.4%68.0%64.7%66.3%66.4%66.4%66.1%67.8%
Operating margin28.3%30.4%25.7%30.5%30.3%30.2%30.9%33.6%
Net margin27.7%28.4%31.0%27.0%28.1%27.7%29.6%28.3%

Revenue by product

LineFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Instruments and accessories$1.6B$2B$2.4B$2.5B$3.1B$3.5B$4.3B$5.1B$6B
Systems$928.4M$1.1B$1.3B$1.2B$1.7B$1.7B$1.7B$2B$2.5B
Service$572.9M$635.1M$724.2M$723.8M$916.2M$1B$1.2B$1.3B$1.6B

* derived: a fourth quarter as the year less the three filed quarters, or a remainder as the total less the parts. All other figures are as filed.

About this page

Every figure on this page is read from Intuitive Surgical's own SEC filings: the statement lines from the SEC's XBRL company-facts feed, the revenue splits from the segment and revenue notes of each 10-K and 10-Q. Nothing is typed in or estimated. The cache refreshes daily.

Read the Risk & Quality report on Intuitive Surgical or see all companies.

More in Healthcare & Pharma